The food and beverage industries are seeing a fast-changing regulatory landscape at both the federal and state levels. These efforts are being driven primarily by the US Department of Health and Human Services (the “HHS”),...more
The legal battle over the scope of orphan drug exclusivity continues, as the U.S. Food and Drug Administration (“FDA”) has recently lost a second case concerning the exclusivity provisions of the Orphan Drug Act (“ODA”)....more
On June 11, 2025, in a memorandum entitled Civil Division Enforcement Priorities (the “Memo”), the Department of Justice (DOJ) Civil Division outlined its five priority areas for investigations and enforcement actions: (1)...more
6/26/2025
/ Department of Justice (DOJ) ,
Diversity and Inclusion Standards (D&I) ,
Educational Institutions ,
Employment Discrimination ,
Enforcement Actions ,
Enforcement Priorities ,
Executive Orders ,
False Claims Act (FCA) ,
Federal Contractors ,
Gender Identity ,
Health Care Providers ,
Healthcare ,
Immigration Enforcement ,
Trump Administration
On April 22, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) announced a series of steps intended to eliminate all petroleum-based synthetic dyes from the US food...more
On April 30, 2024, the US Federal Trade Commission (“FTC”) announced that it had sent “warning letters” to 10 branded pharmaceutical manufacturers, alleging that the companies had made “improper or inaccurate listing of...more